These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3625293)

  • 1. Hepatic visualization on iodine-131 whole-body thyroid cancer scans.
    Ziessman HA; Bahar H; Fahey FH; Dubiansky V
    J Nucl Med; 1987 Sep; 28(9):1408-11. PubMed ID: 3625293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of hepatic visualization on iodine-131 whole-body scan in patients with thyroid carcinoma.
    Chung JK; Lee YJ; Jeong JM; Lee DS; Lee MC; Cho BY; Koh CS
    J Nucl Med; 1997 Aug; 38(8):1191-5. PubMed ID: 9255147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of hepatic visualization during I-131 imaging for metastatic thyroid carcinoma.
    Rosenbaum RC; Johnston GS; Valente WA
    Clin Nucl Med; 1988 Sep; 13(9):657-60. PubMed ID: 3180614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementary role of whole body scan and serum thyroglobulin determination in the follow-up of differentiated thyroid carcinoma.
    Ronga G; Fiorentino A; Fragasso G; Fringuelli FM; Todino V
    Ital J Surg Sci; 1986; 16(1):11-5. PubMed ID: 3087907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of the 131I whole-body scan in postsurgical therapy for differentiated thyroid cancer.
    Pupi A; Castagnoli A; Morotti A; La Cava G; Meldolesi U
    Cancer; 1983 Aug; 52(3):439-41. PubMed ID: 6407747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma.
    Lubin E; Mechlis-Frish S; Zatz S; Shimoni A; Segal K; Avraham A; Levy R; Feinmesser R
    J Nucl Med; 1994 Feb; 35(2):257-62. PubMed ID: 8294995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical value of serum thyroglobulin and 131I-whole body retention measurements in the diagnosis of metastases from differentiated thyroid carcinoma (author's transl)].
    Weissel M; Bergmann H; Höfer R
    Acta Med Austriaca; 1980; 7(4-5):114-9. PubMed ID: 7246011
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical implications of diffuse hepatic uptake observed in postablative and post-therapeutic I-131 scans.
    Omür O; Akgün A; Ozcan Z; Sen C; OzkiIiç H
    Clin Nucl Med; 2009 Jan; 34(1):11-4. PubMed ID: 19092374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thallium-201 scintigraphy in differentiated thyroid cancer: comparison with radioiodine scintigraphy and serum thyroglobulin determinations.
    Ramanna L; Waxman A; Braunstein G
    J Nucl Med; 1991 Mar; 32(3):441-6. PubMed ID: 2005453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroglobulin and 131I uptake of remaining tissue in patients with differentiated carcinoma after thyroidectomy.
    Moser E; Fritsch S; Braun S
    Nucl Med Commun; 1988 Apr; 9(4):262-6. PubMed ID: 3399222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of diffuse hepatic visualization and thyroid bed uptake on post-ablative iodine-131 whole body scan in differentiated thyroid cancer.
    Kim K; Kim SJ; Kim IJ; Kim YK; Kim BS; Pak K
    Onkologie; 2012; 35(3):82-6. PubMed ID: 22414970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gallbladder visualization during post-therapy iodine-131 imaging of thyroid carcinoma.
    Achong DM; Oates E; Lee SL; Doherty FJ
    J Nucl Med; 1991 Dec; 32(12):2275-7. PubMed ID: 1744714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metastatic differentiated thyroid cancer. Diagnostic accuracy of thyroglobulin-RIA in comparison with 131I-whole body scintigraphy].
    Reiners C; Reimann J; Schäffer R; Baum K; Becker W; Eilles C; Gerhards W; Schick F; Spiegel W; Wiedemann W
    Rofo; 1984 Sep; 141(3):306-13. PubMed ID: 6435198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insensitivity of Tc-99m pertechnetate for detecting metastases of differentiated thyroid carcinoma.
    Campbell CM; Khafagi FA
    Clin Nucl Med; 1990 Jan; 15(1):1-4. PubMed ID: 2155079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iodine-131 treatment of thyroid cancer: absorbed dose calculated from post-therapy scans.
    Koral KF; Adler RS; Carey JE; Beierwaltes WH
    J Nucl Med; 1986 Jul; 27(7):1207-11. PubMed ID: 3723194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can iodine-131 whole-body scan be replaced by thyroglobulin measurement in the post-surgical follow-up of differentiated thyroid carcinoma?
    Ronga G; Fiorentino A; Paserio E; Signore A; Todino V; Tummarello MA; Filesi M; Baschieri I
    J Nucl Med; 1990 Nov; 31(11):1766-71. PubMed ID: 2121913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of diagnostic radioiodines on the uptake of ablative dose of iodine-131.
    Park HM; Perkins OW; Edmondson JW; Schnute RB; Manatunga A
    Thyroid; 1994; 4(1):49-54. PubMed ID: 8054861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Increased sensitivity of whole-body scintigraphy with I131 for the detection of iodine-accumulating metastases by means of delayed imaging].
    Briele B; Hotze A; Grünwald F; Overbeck B; Biersack HJ
    Nuklearmedizin; 1990 Dec; 29(6):264-8. PubMed ID: 2075087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thyroglobulin, 131I-whole body scintigraphy and risk factors in the follow-up of differentiated thyroid cancer].
    Berding G; Hüfner M; Georgi P
    Nuklearmedizin; 1992 Feb; 31(1):32-7. PubMed ID: 1561118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroglobulin radioimmunoassay and 131I scintigraphy in patients with differentiated thyroid carcinoma.
    Lindegaard MW; Paus E; Høie J; Kullman G; Stenwig AE
    Acta Chir Scand; 1988 Feb; 154(2):141-5. PubMed ID: 3354295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.